Literature DB >> 23391859

Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors.

C M Pacella1, E Papini.   

Abstract

The incidence of thyroid carcinoma has increased steadily over the last few decades. Most differentiated thyroid carcinomas (DTC) are cured thanks to the initial treatment with surgery and radioiodine therapy. Nevertheless, neck lymph node metastases are found in a few of these patients during their long-term clinical and ultrasound follow-up. In some of these cases radioiodine treatment may not be effective in eradicating nodal metastases due to scant 131-I uptake. Additionally, a few of these patients undergo repeated neck explorations and/or resections. Based on these considerations and on the frequently indolent course of DTC neck metastases, a non-surgical therapeutic approach should be considered to control small local foci of DTC. There is increasing interest in mini-invasive image-guided procedures that can be performed under local anesthesia which do not affect the performance status of the patient. Image-guided minimally invasive ablative therapies delivered by using needle-like applicators include both thermal and non-thermal source techniques. Over the past 25 years, these therapies have gained widespread attention and, in many cases, broad clinical acceptance as methods for treating focal malignancies. In an attempt to overcome the limitations of treating certain unresectable tumor types not amenable to a further surgical treatment, a few investigators have reported successfully combining percutaneous therapies with other oncologic treatment strategies (combined treatments). In this review, we reported mini-invasive techniques more commonly employed in selected cases to ameliorate local compressive symptoms, control hormonal production, and reduce the volume of neoplastic tissue prior to traditional palliative treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23391859     DOI: 10.1007/BF03346744

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  106 in total

1.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.

Authors:  H Gharib; E Papini; R Paschke; D S Duick; R Valcavi; L Hegedüs; P Vitti
Journal:  J Endocrinol Invest       Date:  2010       Impact factor: 4.256

2.  A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules.

Authors:  G Gambelunghe; C Fatone; A Ranchelli; C Fanelli; P Lucidi; A Cavaliere; N Avenia; M d'Ajello; F Santeusanio; P De Feo
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 3.  Laser ablation of hepatocellular carcinoma--a review.

Authors:  Antony Lawrence Gough-Palmer; Wladyslaw Michal Witold Gedroyc
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

4.  Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound.

Authors:  O Esnault; A Rouxel; E Le Nestour; G Gheron; L Leenhardt
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

5.  Hepatic ablation using radiofrequency electrocautery.

Authors:  J P McGahan; P D Browning; J M Brock; H Tesluk
Journal:  Invest Radiol       Date:  1990-03       Impact factor: 6.016

6.  Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma.

Authors:  Arne Heilo; Eva Sigstad; Kristin Holgersen Fagerlid; Olav Inge Håskjold; Krystyna Kotanska Grøholt; Aasmund Berner; Trine Bjøro; Lars H Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2011-06-29       Impact factor: 5.958

7.  Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies.

Authors:  Bing Feng; Ping Liang; Zhigang Cheng; Xiaoling Yu; Jie Yu; Zhiyu Han; Fangyi Liu
Journal:  Eur J Endocrinol       Date:  2012-03-23       Impact factor: 6.664

8.  Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma.

Authors:  J W Charboneau; I D Hay; J A van Heerden
Journal:  Mayo Clin Proc       Date:  1988-09       Impact factor: 7.616

9.  Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.

Authors:  W L Tsai; J S Cheng; K H Lai; C P Lin; G H Lo; P I Hsu; H C Yu; C K Lin; H H Chan; W C Chen; T A Chen; W L Li; H L Liang
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

10.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

View more
  9 in total

1.  Transoral thyroidectomy: advantages and limitations.

Authors:  G Dionigi; R P Tufano; J Russell; H Y Kim; E Piantanida; A Anuwong
Journal:  J Endocrinol Invest       Date:  2017-04-21       Impact factor: 4.256

2.  Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation.

Authors:  Lou Zhong; Siyuan Sun; Jiahai Shi; Fei Cao; Xiao Han; Xueping Bao; Qingsheng You
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Recent developments in the follow-up, prevention and management of complications in thyroid surgery.

Authors:  Maria Laura Tanda; Che-Wei Wu; Gianlorenzo Dionigi
Journal:  Gland Surg       Date:  2017-10

4.  Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.

Authors:  Hyun Kyung Lim; Jung Hwan Baek; Jeong Hyun Lee; Won Bae Kim; Tae Yong Kim; Young Kee Shong; Suck Joon Hong
Journal:  Eur Radiol       Date:  2014-09-09       Impact factor: 5.315

Review 5.  The Efficacy and The Safety of Ultrasound-guided Ablation Therapy for Treating Papillary Thyroid Microcarcinoma.

Authors:  Jifan Chen; Jing Cao; Fuqiang Qiu; Pintong Huang
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

6.  Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma.

Authors:  Wei Chen; Yu Kun Luo; Ying Zhang; Qing Song; Jie Tang
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

7.  Ultrasound-Guided Percutaneous Ethanol Injection Protocol to Treat Solid and Mixed Thyroid Nodules.

Authors:  João Soares Felício; Antônio Maria Silva Conceição; Flávia Marques Santos; Michelle Masuyo Minami Sato; Fabíola de Arruda Bastos; Ana Carolina Contente Braga de Souza; Camila Cavalcante Koury; João Felício Abrahão Neto; Franciane Trindade Cunha de Melo; Carolina Tavares Carvalho; Thaís Pontes Arbage; Antonio Bentes de Figueiredo Junior; Hana Andrade de Rider Brito; Marcelo Oliveira Mourão Júnior; Fabricio de Souza Resende; Amanda Soares Peixoto; Karem Miléo Felício
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-06       Impact factor: 5.555

8.  Morphological Changes Induced by Bipolar Radiofrequency Ablation in Thyroid Nodules - a Preclinical Ex Vivo Investigation.

Authors:  Daniel Igor Branovan; Mikhail Fridman; Maxim Lushchyk; Valentina Drozd; Olga Krasko; Olga Nedzvedz; Nikolay Shiglik; Larisa Danilova
Journal:  Eur Endocrinol       Date:  2016-08-28

9.  A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.

Authors:  Xian Wang; Shan Huang; Xiaocan Li; Dongrui Jiang; Hongzhen Yu; Qiang Wu; Chaobing Gao; Zhengsheng Wu
Journal:  PLoS One       Date:  2018-07-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.